KCU-33418-48042
3 vaccinations
12 coded responses
39 check-ins
12 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 957 / CA
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Pfizer-BioNTech
- 2020-12-28
-
2020-12-29
Survey response — days 1–6 daily, dose 1MedDRA: Joint noise, Joint stiffness — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Joint popping and stiffnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-29
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-30
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
-
2021-01-04
Survey response — day 7, dose 1MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-18
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-01-19
- 2021-01-20
- 2021-01-21
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Rhinorrhoea — Feeling: Good · Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Health check-in — day 7, dose 2Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-02
- 2021-02-11
- 2021-02-16
- 2021-02-23
- 2021-03-05
-
2021-04-20
Survey response — 3 months, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: TirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-20
Survey response — 6 months, dose 2MedDRA: Chest pain, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Chest pain, possibly esophageal ulcerMedDRA releases: 2024-11 · check-in free text available
-
2021-07-20
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-21
-
2021-09-30
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Dyspnoea, Increased viscosity of upper respiratory secretion — Feeling: Fair · Joint pains, Muscle or body aches, Abdominal pain · Be unable to do your normal daily activitiesFree text: Difficulty breathing/cough/thick mucusMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-10-06
-
2021-10-07
Health check-in — day 7, dose 3Feeling: Fair · Site: Itching · Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-14
Survey response — day 14, dose 3MedDRA: Body temperature decreased, Chills, Dizziness, Headache, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Extreme headache, nausea, chills, 95F, dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Survey response — day 21, dose 3MedDRA: Chills, Fatigue, Headache, Nasal congestion, Nausea, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, fatigue, chills, nasal congestion and runny nose, nauseaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Survey response — day 28, dose 3MedDRA: Abdominal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Abdominal pain and crampingMedDRA releases: 2024-11 · check-in free text available
- 2021-11-13
- 2022-01-01
- 2022-03-31
-
2022-09-30
Survey response — 12 months, dose 3MedDRA: Pregnancy, Spinal column injury — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pregnancy and tailbone injuryMedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-03
- 2022-10-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Call center
4 call center cases
2 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Joint popping and stiffness
Systemic reaction (other): Runny nose
Release 1 — day 7, dose 1
Systemic reaction (other): Runny nose
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Systemic reaction (other): Runny nose
Release 7 — 3 months, dose 2
Symptoms: Tiredness
Release 9 — 6 months, dose 2
Symptoms: Chest pain, possibly esophageal ulcer
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Difficulty breathing/cough/thick mucus
Release 10 — day 14, dose 3
Symptoms: Extreme headache, nausea, chills, 95F, dizziness
Release 10 — day 21, dose 3
Symptoms: Headache, fatigue, chills, nasal congestion and runny nose, nausea
Release 10 — day 28, dose 3
Symptoms: Abdominal pain and cramping
Release 12 — 12 months, dose 3
Symptoms: Pregnancy and tailbone injury
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | · | · | ✓ |
| SD | Body temperature decreased | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Spinal column injury | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Increased viscosity of upper respiratory secretion | · | · | ✓ |
| SRO | Joint noise | ✓ | ✓ | ✓ |
| SRO | Joint stiffness | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release